Systematic review of EEG findings in 617 patients diagnosed with COVID-19.
Systematic review of EEG findings in 617 patients diagnosed with COVID-19.
复制标题
DOI:
10.1016/j.seizure.2020.10.014
复制
发表时间:
2020-12
期刊:
影响因子:
--
通讯作者:
Haneef Z
中科院分区:
文献类型:
--
作者:
Antony AR;Haneef Z
We performed a systematic review of the literature to synthesize the data on EEG findings in COVID-19. Frontal EEG patterns are reported to be a characteristic finding in COVID-19 encephalopathy. Although several reports of EEG abnormalities are available, there is lack of clarity about typical findings. Research databases were queried with the terms “COVID” OR “coronavirus” OR “SARS” AND “EEG”. Available data was analyzed from 617 patients with EEG findings reported in 84 studies. The median age was 61.3 years (IQR 45−69, 33.3 % female). Common EEG indications were altered mental status (61.7 %), seizure-like events (31.2 %), and cardiac arrest (3.5 %). Abnormal EEG findings (n = 543, 88.0 %) were sub-classified into three groups: (1) Background abnormalities: diffuse slowing (n = 423, 68.6 %), focal slowing (n = 105, 17.0 %), and absent posterior dominant rhythm (n = 63, 10.2 %). (2) Periodic and rhythmic EEG patterns: generalized periodic discharges (n = 35, 5.7 %), lateralized/multifocal periodic discharges (n = 24, 3.9 %), generalized rhythmic activity (n = 32, 5.2 %). (3) Epileptiform changes: focal (n = 35, 5.7 %), generalized (n = 27, 4.4 %), seizures/status epilepticus (n = 34, 5.5 %). Frontal EEG patterns comprised of approximately a third of all findings. In studies that utilized continuous EEG, 96.8 % (n = 243) of the 251 patients were reported to have abnormalities compared to 85.0 % (n = 311) patients who did not undergo continuous EEG monitoring (χ2 = 22.8, p =< 0.001). EEG abnormalities are common in COVID-19 related encephalopathy and correlates with disease severity, preexisting neurological conditions including epilepsy and prolonged EEG monitoring. Frontal findings are frequent and have been proposed as a biomarker for COVID-19 encephalopathy.
登录
查看更多内容
影响因子:
11.8
作者:
Lau KK;Yu WC;Chu CM;Lau ST;Sheng B;Yuen KY
通讯作者:
Yuen KY
影响因子:
5.3
作者:
Butt, Isabel;Sawlani, Vijay;Geberhiwot, Tarekegn
通讯作者:
Geberhiwot, Tarekegn
影响因子:
3
作者:
Galanopoulou, Aristea S.;Ferastraoaru, Victor;Boro, Alexis
通讯作者:
Boro, Alexis
影响因子:
1.2
作者:
Farley, Madison;Zuberi, Jamshed
通讯作者:
Zuberi, Jamshed
影响因子:
2.6
作者:
Garcia-Howard, Marcos;Herranz-Aguirre, Mercedes;Aguilera-Albesa, Sergio
通讯作者:
Aguilera-Albesa, Sergio